Somerville Kurt F Acquires Shares of 3,350 SPDR S&P Biotech ETF $XBI

Somerville Kurt F acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 3,350 shares of the exchange traded fund’s stock, valued at approximately $294,000.

A number of other institutional investors have also recently modified their holdings of XBI. Bank of America Corp DE increased its position in shares of SPDR S&P Biotech ETF by 13.3% in the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock worth $1,854,388,000 after purchasing an additional 1,700,851 shares during the period. Morgan Stanley increased its holdings in SPDR S&P Biotech ETF by 8.3% in the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after buying an additional 882,718 shares during the period. Wells Fargo & Company MN increased its holdings in SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after buying an additional 1,536,122 shares during the period. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $256,053,000. Finally, Bessemer Group Inc. increased its stake in SPDR S&P Biotech ETF by 13.5% in the fourth quarter. Bessemer Group Inc. now owns 1,853,232 shares of the exchange traded fund’s stock valued at $225,965,000 after acquiring an additional 220,244 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of XBI opened at $169.55 on Thursday. SPDR S&P Biotech ETF has a one year low of $88.18 and a one year high of $169.68. The company has a market cap of $11.07 billion, a P/E ratio of 11.47 and a beta of 0.83. The firm has a 50 day simple moving average of $152.74 and a two-hundred day simple moving average of $137.22.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.